Drug intelligence / Profile preview

Pelton-C

Development stage
Unknown
Lead developer
Global Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Pelton-C is a combination pharmaceutical product developed and marketed by Global Pharmaceuticals in Pakistan. It contains domperidone maleate and cinnarizine as its active ingredients. Domperidone is a peripheral dopamine D2 receptor antagonist that acts as a prokinetic agent, increasing gastrointestinal motility and preventing nausea and vomiting by blocking dopamine receptors in the chemoreceptor trigger zone. Cinnarizine is a calcium channel blocker and H1-receptor antagonist that acts primarily on the vestibular system to alleviate symptoms of vertigo and motion sickness. This combination is typically indicated for the treatment of nausea, vomiting, and vestibular disorders such as vertigo and motion sickness, providing a dual mechanism to address both gastrointestinal and vestibular symptoms.

Brand names
Pelton-C
02

Targets

DRD3 (Dopamine receptor D3)CaV (Voltage-gated calcium channel protein complex)DRD2 (Dopamine D2 Receptor)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Pelton-C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pelton-C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call